Skip to main content
. 2023 Jan 4;13:1022638. doi: 10.3389/fimmu.2022.1022638

Table 1.

Patient characteristic.

Variables Total 99(100%) Recurrence 52(53%) Non-Recurrence 47(47%) P
Age 1.000
 >65y 27 (27) 14 (52) 13 (48)
 ≤65y 72 (73) 38 (53) 34 (47)
Gender 0.227
 female 31 (31) 13 (42) 18 (58)
 male 68 (69) 39 (57) 29 (43)
KPS 0.407
 ≥90 60 (61) 29 (48) 31 (52)
 <90 39 (39) 23 (59) 16 (41)
Smoking index 0.084
 <400 51 (52) 22 (43) 29 (57)
 ≥400 48 (48) 30 (63) 18 (37)
Tumor location 0.924
 central 49 (49) 25 (51) 24 (49)
 peripheral 50 (51) 27 (54) 23 (46)
Visceral pleural invasion 1.000
 yes 51 (52) 27 (53) 24 (47)
 no 48 (48) 25 (52) 23 (48)
Histology subtype 0.604
 SCC 48 (48) 27 (56) 21 (44)
 ADC 51 (52) 25 (49) 26 (51)
Pathologic stage 0.055
 IIB 47 (47) 19 (40) 28 (60)
 IIIA 48 (48) 30 (63) 18 (37)
 IIIB 4 (4) 3 (75) 1 (25)
Adjuvant chemotherapy 0.620
 yes 87 (88) 47 (54) 40 (46)
 no 12 (12) 5 (42) 7 (58)
Adjuvant radiotherapy 0.609
 yes 22 (22) 10 (45) 12 (55)
 no 77 (78) 42 (55) 35 (45)

Statistical significance determined by two-sided Chi-square test. KPS, Karnofsky performance status; SCC, Squamous cell carcinoma; ADC, Adenocarcinoma.